Christine Chung - Jun 13, 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
SVP, China Operations
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Jun 13, 2023
Transactions value $
-$214,925
Form type
4
Date filed
6/15/2023, 08:17 PM
Previous filing
Jun 9, 2023
Next filing
Sep 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$110K -6.25K -2.51% $17.60* 243K Jun 13, 2023 Direct F1, F2
transaction FGEN Common Stock Sale -$87.5K -5.25K -2.16% $16.66* 237K Jun 14, 2023 Direct F1, F3
transaction FGEN Common Stock Sale -$17.5K -1K -0.42% $17.46* 236K Jun 14, 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 trading plan.
F2 The shares were sold at prices ranging from $17.31 to $18.18. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The shares were sold at prices ranging from $16.34 to $17.32. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The shares were sold at prices ranging from $17.37 to $17.61. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.